Skip to main content
Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.025
-0.005 (-0.25%)
Nov 21, 2024, 10:44 AM EST - Market open

Stereotaxis Revenue

Stereotaxis had revenue of $9.20M in the quarter ending September 30, 2024, with 17.91% growth. This brings the company's revenue in the last twelve months to $25.14M, down -14.79% year-over-year. In the year 2023, Stereotaxis had annual revenue of $26.77M, down -4.89%.

Revenue (ttm)
$25.14M
Revenue Growth
-14.79%
P/S Ratio
6.79
Revenue / Employee
$206,090
Employees
122
Market Cap
171.58M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202326.77M-1.38M-4.89%
Dec 31, 202228.15M-6.87M-19.63%
Dec 31, 202135.02M8.39M31.51%
Dec 31, 202026.63M-2.27M-7.86%
Dec 31, 201928.90M-444.07K-1.51%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nutex Health 292.00M
The Joint 120.80M
2seventy bio 45.62M
scPharmaceuticals 30.28M
MediWound 20.14M
Lineage Cell Therapeutics 8.72M
Revenue Rankings

STXS News

More News